Repository logo
 

Silver Clusters of Five Atoms as Highly Selective Antitumoral Agents Through Irreversible Oxidation of Thiols

Published version
Peer-reviewed

Change log

Authors

Porto, V 
Buceta, D 
Domínguez, B 
Carneiro, C 
Borrajo, E 

Abstract

jats:titleAbstract</jats:title>jats:pLow atomicity clusters present properties dependent on the size, due to the quantum confinement, with well‐defined electronic structures and high stability. Here it is shown that Agjats:sub5</jats:sub> clusters catalyze the complete oxidation of sulfur to Sjats:sup+6</jats:sup>. Agjats:sub5</jats:sub> catalytic activity increases with different oxidant species in the order Ojats:sub2</jats:sub> ≪ Hjats:sub2</jats:sub>Ojats:sub2</jats:sub> jats:bold<</jats:bold> OH•. Selective oxidation of thiols on the cysteine residues of glutathione and thioredoxin is the primary mechanism human cells have to maintain redox homeostasis. Contingent upon oxidant concentration, Agjats:sub5</jats:sub> catalyzes the irreversible oxidation of glutathione and thioredoxin, triggering apoptosis. Modification of the intracellular environment to a more oxidized state to mimic conditions within cancer cells through the expression of an activated oncogene (HRASjats:supG12V</jats:sup>) or through ARID1A mutation, sensitizes cells to Agjats:sub5</jats:sub> mediated apoptosis. While cancers evolve to evade treatments designed to target pathways or genetic mutations that drive them, they cannot evade a treatment that takes advantage of aberrant redox homeostasis, which is essential for tumor progression and metastasis. Agjats:sub5</jats:sub> has antitumor activity in mice with orthotopic lung tumors reducing primary tumor size, and the burden of affected lymphatic nodes. The findings suggest the unique intracellular redox chemistry of Agjats:sub5</jats:sub> may lead to new redox‐based approaches to cancer therapy.</jats:p>

Description

Keywords

cancer therapy, catalysis, low atomicity clusters, silver clusters, sulfur oxidation

Journal Title

Advanced Functional Materials

Conference Name

Journal ISSN

1616-301X
1616-3028

Volume Title

Publisher

Wiley
Sponsorship
Medical Research Council (MC_U105663142)
European Commission Horizon 2020 (H2020) Research Infrastructures (RI) (823717)